ORIC Pharmaceuticals Inc
ORIC Pharmaceuticals Inc Stock, NASDAQ:ORIC
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in August 2014 and is headquartered in South San Francisco, CA.